Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years of age at the time of signing the consent form
- People with active rheumatoid arthritis, measured by a disease activity score above 3.2, with at least 4 tender and 4 swollen joints (out of 28 joints assessed)
- People whose rheumatoid arthritis did not respond well enough to, stopped responding to, or who could not tolerate at least one approved biologic or targeted medication for rheumatoid arthritis, including a type of drug known as JAK inhibitors
- People who have been on a stable dose of steroid medications for at least 2 weeks, or stable dose of conventional disease-modifying arthritis drugs for at least 4 weeks, before the screening visit
Who may not be able to join:
- People who have had a surgical procedure that cuts or removes part of the vagus nerve (a nerve running from the brain to the abdomen)
- People who have had part or all of their spleen removed
- People who experience repeated episodes of fainting caused by a sudden drop in heart rate or blood pressure
- People with a psychiatric illness that is untreated or not well managed
- People with a significantly weakened immune system due to an underlying health condition
- People who have had a stroke or similar brain blood vessel event in the past
- People with a serious heart or cardiovascular condition
- People with fibromyalgia that is not well controlled
- People who are pregnant (the trial requires sexually active participants to use a reliable form of contraception, or to be at least 2 years past menopause)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ulf Andersson, Professor, taVNS AB
Phone: +46 12370000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ACR 20 response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.